The applied voltage creates an electrostatic force at the liquid meniscus. As this force overcomes surface tension, the meniscus extends into a Taylor cone and emits a jet toward the collector. This sequence is important because it converts the feed liquid into a stream that can fragment into charged droplets, establishing the physical basis for particle fabrication.
Solvent evaporation determines whether droplets remain liquid or leave solid particles during flight to the collector. As solvent leaves, material carried by each droplet becomes concentrated and solidifies. In electrospraying, this transition is central to producing polymeric micro- or nanoparticles rather than simply collecting an unchanged liquid.
Polymeric formulations can carry chemotherapeutic agents, proteins, and other bioactive compounds. Encapsulation places these cargos within micro- or nanoparticles, which can protect them while the material is prepared for delivery. This is particularly useful when a cancer research formulation must combine a therapeutic payload with a carrier designed to support localized administration or controlled release.
An electrospraying setup requires a liquid feed, a needle, a high-voltage source, and a collector. Researchers apply the voltage between needle and collector, form the Taylor cone at the meniscus, and allow the emitted jet to break into droplets. Solvent evaporation then leaves particles on the collector for drug-delivery material or coating fabrication.
Encapsulated cargo can be incorporated into polymeric particles or coatings intended to support localized delivery. Keeping therapeutic material within a fabricated carrier may also protect the cargo and enable controlled release. These features make the technique relevant to cancer research focused on localized treatment strategies.
The technique can accommodate chemotherapeutic agents, proteins, and other bioactive compounds within polymeric micro- or nanoparticles. That flexibility supports research on targeted treatments and combination therapies, where a fabricated carrier may be designed around more than one therapeutic objective. The resulting materials can support cargo protection, localized delivery, and controlled-release behavior.